University at Buffalo - The State University of New York
Skip to Content

Pharmacy Law Newsletter is an online website from the University at Buffalo School of Pharmacy and Pharmaceutical Sciences, covering pharmacy practice laws in New York State.

Pharmacy Law Newsletter was created in 1993 by the late Robert M. Cooper, PharmD, a long-time UB faculty member and a member of the New York State Board of Pharmacy. It was his dream to bring current, concise, and accurate information to practicing pharmacists.

Recent Updates

DEA Proposes Quotas on Controlled Substances for 2018

The Drug Enforcement Administration has proposed a 20% reduction for controlled substances to be manufactured in 2018 as compared to 2017.  The August 7, 2017 Federal Register has reported that the DEA intends to reduce the 2018 production quotas for Schedules I and II of the Federal Controlled Substance Act while assessing the annual needs of the List 1 chemicals:  ephedrine, pseudoephedrine and phenylpropanolamine.  Schedule II drugs slated for reduction quotas include codeine, hydrocodone, hydromorphone, oxycodone, morphine, meperidine and fentanyl.

Aggregate production quotas for Schedule I and II drugs and List 1 chemicals are determined for the estimated medical, scientific, research and industrial needs domestically, for lawful export requirements and for maintenance of reserve stocks.  The DEA considers:

  1. The total net disposal by all manufacturers during the current and two years preceding the year in question.
  2. Trends in the national rate of disposal
  3. Total actual, or estimated inventories of all substances or chemicals manufactured in the class and any inventory accumulations
  4. Projected demand, which has dropped recently according to the DEA
  5. Any other factors affecting the medical, scientific, research and industrial needs in the US and the lawful exports of the drug.

The purpose of the quotas are to provide the uninterrupted supply for legitimate medical needs of Schedule I and Schedule II controlled substances while limiting the amounts available to prevent diversion.

Since this is a proposed ruling, comments may be submitted up until October 6, 2017 (60 days).  All comments concerning this proposed rule may be sent to the DEA at http://www.regulations.gov and are available for public inspection online.   Revisions to the aggregate quota by the DEA may be warranted during the year if changes occur due to increased sales or exports; new manufacturers entering the marketplace, new product development or product recalls. 

Pharmacies Now Required to Provide Patients with Information about Controlled Substance Prescriptions

As of October 22, 2016, pharmacies are now required to give information to the patient about any controlled substance prescription that is being dispensed. This information is provided by the NYS Office of Alcoholism and Substance Abuse Services (NYS OASAS) and the NYS Department of Health Bureau of Controlled Substances (BNE) and must include the “…dangers of misuse and the potential for addiction to prescription controlled substances, the physical and behavioral warning signs of addiction, treatment resources available and the proper way to dispose of unused prescription controlled substances…”  among other items. The pharmacy may provide additional information and resources for the safe disposal if so desired. 

Further, this information must be provided in languages other than English as deemed appropriate by the NYS Commissioner of Health (up to the 10 most common languages in NYS). Pharmacies may provide this information to the patient electronically if so requested by the patient. Please see the following important documents:

The Legal Stuff

© 2017 by the Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any mechanical or electronic means—photocopying, recording, or otherwise—without the prior permission, in writing, of the publisher.

Pharmacy Law is published as an educational service to the pharmacy community in New York State. Its sole purpose is to promote an understanding of the laws, rules, and regulations that affect the practice of pharmacy in New York. Because Pharmacy Law is a periodical about legal issues, the information is subject to change with little or no notice. The law is dynamic, and discrete facts should be verified before they are relied upon. Pharmacy Law is intended to inform, but not to provide legal advice. For specific legal problems, readers should seek legal counsel. The publisher, editor, advisory board, authors, and University at Buffalo do not hold themselves out as offering legal advice.

Editor's Column

Karl Fiebelkorn, MBA, RPh
Director/Editor

After months of preparation we are embarking on a new venture based on our previous publication: Pharmacy Law Newsletter. Our mission remains the same: To provide the practicing pharmacist in New York State with current, concise, and accurate information about pharmacy practice laws, rules, and regulations.

 

We plan on posting articles and links of interest. The law is not static, but dynamic, changing frequently along with our ever-growing profession. Many laws, rules, and regulations have changed over the past few years and many will do so in the future.  We hope to bring you notices of the latest changes as they happen.

 

As we continue to build and modify our website we hope you will use us as a source for your pharmacy law queries and questions.  There are sections to download important forms that pharmacists need to use, as well as handy searchable downloads for common regulations. Feel free to send us questions or comments via our new “E-Mailbag” tab.

 

I look forward to hearing from you!

 

Karl

"); pageTracker._trackPageview();